Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.
Identifieur interne : 000178 ( Main/Exploration ); précédent : 000177; suivant : 000179Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.
Auteurs : Shivani Mathur Gaiha [États-Unis] ; Lauren Kass Lempert [États-Unis] ; Bonnie Halpern-Felsher [États-Unis]Source :
- JAMA network open [ 2574-3805 ] ; 2020.
Descripteurs français
- KwdFr :
- Adolescent (MeSH), Comportement du consommateur (statistiques et données numériques), Dispositifs électroniques d'administration de nicotine (statistiques et données numériques), Enquêtes et questionnaires (MeSH), Femelle (MeSH), Humains (MeSH), Jeune adulte (MeSH), Minorités sexuelles (statistiques et données numériques), Mâle (MeSH), Quarantaine (statistiques et données numériques), Trouble lié au tabagisme (épidémiologie), Vapotage (épidémiologie), États-Unis (épidémiologie), Études transversales (MeSH).
- MESH :
- statistiques et données numériques : Comportement du consommateur, Dispositifs électroniques d'administration de nicotine, Minorités sexuelles, Quarantaine.
- épidémiologie : Trouble lié au tabagisme, Vapotage, États-Unis.
- Adolescent, Enquêtes et questionnaires, Femelle, Humains, Jeune adulte, Mâle, Études transversales.
- Wicri :
- geographic : États-Unis.
English descriptors
- KwdEn :
- Adolescent (MeSH), COVID-19 (MeSH), Consumer Behavior (statistics & numerical data), Cross-Sectional Studies (MeSH), Electronic Nicotine Delivery Systems (statistics & numerical data), Female (MeSH), Humans (MeSH), Male (MeSH), Quarantine (statistics & numerical data), SARS-CoV-2 (MeSH), Sexual and Gender Minorities (statistics & numerical data), Surveys and Questionnaires (MeSH), Tobacco Use Disorder (epidemiology), United States (epidemiology), Vaping (epidemiology), Young Adult (MeSH).
- MESH :
- geographic , epidemiology : United States.
- epidemiology : Tobacco Use Disorder, Vaping.
- statistics & numerical data : Consumer Behavior, Electronic Nicotine Delivery Systems, Quarantine, Sexual and Gender Minorities.
- Adolescent, COVID-19, Cross-Sectional Studies, Female, Humans, Male, SARS-CoV-2, Surveys and Questionnaires, Young Adult.
Abstract
Importance
Understanding patterns of e-cigarette use and access during the coronavirus disease 2019 (COVID-19) pandemic is important because e-cigarettes may put users at risk for more severe respiratory effects and other health problems.
Objective
To examine whether underage youth and young adults who ever used e-cigarettes self-reported changes in access and use of e-cigarettes since the COVID-19 pandemic began.
Design, Setting, and Participants
A national, cross-sectional online survey study was conducted from May 6 to May 14, 2020. This sample of 4351 participants aged 13 to 24 years across the US included 2167 e-cigarette ever-users. Quota sampling was used to balance for age, sex, race/ethnicity, and 50% having ever used e-cigarettes.
Main Outcomes and Measures
Change in e-cigarette use (increase, decrease, quit, no change, and switch to another product) and access to e-cigarettes (easier or harder, and change in point-of-purchase) before and after the COVID-19 pandemic began, reasons for change, number of times e-cigarettes were used, nicotine dependence, and sociodemographic data.
Results
This study focused on 2167 e-cigarette ever-users among 4351 participants who completed the survey. Among 2167 e-cigarette users, a total of 1442 were younger than 21 years and 725 were aged 21 years or older; 1397 were female (64.5%) and 438 identified as lesbian, gay, bisexual, transgender, queer (20.2%). The survey completion rate was 40%. Since the COVID-19 pandemic began, 1198 of 2125 e-cigarette users (56.4%) changed their use: 388 individuals (32.4%) quit, 422 individuals (35.3%) reduced the amount of nicotine, 211 individuals (17.6%) increased nicotine use, 94 individuals (7.8%) increased cannabis use, and 82 individuals (6.9%) switched to other products. Participants reported that not being able to go to vape shops and product unavailability were the reasons accessing e-cigarettes was difficult after the pandemic began. Since the COVID-19 pandemic began, individuals reported purchasing from alternative retail stores (disposables, 150 of 632 [23.7%]; pod-based, 144 of 797 [18.1%]; and other e-cigarette, 125 of 560 [22.3%], ie, between 18.1% and 23.7%), purchasing online instead of retail (disposables, 115 of 632 [18.2%]; pod-based, 156 of 797 [19.6%]; and other e-cigarette, 111 of 560 [19.8%], ie, between 18.2% to 19.8%), and shifted to retail instead of online (disposables, 11 of 632 [1.7%]; pod-based, 17 of 797 [2.0%]; and other e-cigarette, 13 of 560 [2.3%], ie, between 1.7%-2.3%). Other individuals reported no change: from retail stores (disposables 262 of 632 [41.5%]; pod-based 344 of 797 [43.2%]; and other e-cigarette, 223 of 560 [39.8%], ie, between 39.8% and 43.2%) and online (disposables 94 of 632 [14.9%]; pod-based 136 of 797 [17.1%]; and other e-cigarette, 88 of 560 [15.8%], ie, between 14.9% and 17.1%). Underage youth reported e-cigarette deliveries from vape shops and/or dealers or friends who received such deliveries, and 63 of 229 (27.5%) self-reported accessing e-cigarettes without age verification. e-Cigarette users were 52% less likely to quit or reduce their use if they previously used e-cigarettes between 11 and 99 times (adjusted odds ratio, 0.48; 95% CI, 0.30-0.78), 68% less likely to quit if they previously used e-cigarettes more than 100 times (adjusted odds ratio, 0.32; 95% CI, 0.20-0.51), and 51% were less likely to quit if they were nicotine dependent (adjusted odds ratio, 0.49; 95% CI, 0.35-0.70).
Conclusions and Relevance
During the COVID-19 pandemic, youth e-cigarette users reported changes in e-cigarette use, point-of-purchase, and ability to purchase e-cigarettes without age verification. The US Food and Drug Administration and local policy makers may find these data useful to inform policies to prevent e-cigarette sales to underage youth.
DOI: 10.1001/jamanetworkopen.2020.27572
PubMed: 33270127
PubMed Central: PMC7716191
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.</title>
<author><name sortKey="Gaiha, Shivani Mathur" sort="Gaiha, Shivani Mathur" uniqKey="Gaiha S" first="Shivani Mathur" last="Gaiha">Shivani Mathur Gaiha</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lempert, Lauren Kass" sort="Lempert, Lauren Kass" uniqKey="Lempert L" first="Lauren Kass" last="Lempert">Lauren Kass Lempert</name>
<affiliation wicri:level="3"><nlm:affiliation>Center for Tobacco Control Research & Education, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Center for Tobacco Control Research & Education, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Halpern Felsher, Bonnie" sort="Halpern Felsher, Bonnie" uniqKey="Halpern Felsher B" first="Bonnie" last="Halpern-Felsher">Bonnie Halpern-Felsher</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:33270127</idno>
<idno type="pmid">33270127</idno>
<idno type="doi">10.1001/jamanetworkopen.2020.27572</idno>
<idno type="pmc">PMC7716191</idno>
<idno type="wicri:Area/Main/Corpus">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000132</idno>
<idno type="wicri:Area/Main/Curation">000132</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000132</idno>
<idno type="wicri:Area/Main/Exploration">000132</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.</title>
<author><name sortKey="Gaiha, Shivani Mathur" sort="Gaiha, Shivani Mathur" uniqKey="Gaiha S" first="Shivani Mathur" last="Gaiha">Shivani Mathur Gaiha</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
<author><name sortKey="Lempert, Lauren Kass" sort="Lempert, Lauren Kass" uniqKey="Lempert L" first="Lauren Kass" last="Lempert">Lauren Kass Lempert</name>
<affiliation wicri:level="3"><nlm:affiliation>Center for Tobacco Control Research & Education, University of California, San Francisco.</nlm:affiliation>
<country>États-Unis</country>
<placeName><settlement type="city">San Francisco</settlement>
<region type="state">Californie</region>
</placeName>
<wicri:orgArea>Center for Tobacco Control Research & Education, University of California</wicri:orgArea>
</affiliation>
</author>
<author><name sortKey="Halpern Felsher, Bonnie" sort="Halpern Felsher, Bonnie" uniqKey="Halpern Felsher B" first="Bonnie" last="Halpern-Felsher">Bonnie Halpern-Felsher</name>
<affiliation wicri:level="2"><nlm:affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</nlm:affiliation>
<country>États-Unis</country>
<placeName><region type="state">Californie</region>
</placeName>
<wicri:cityArea>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto</wicri:cityArea>
</affiliation>
</author>
</analytic>
<series><title level="j">JAMA network open</title>
<idno type="eISSN">2574-3805</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adolescent (MeSH)</term>
<term>COVID-19 (MeSH)</term>
<term>Consumer Behavior (statistics & numerical data)</term>
<term>Cross-Sectional Studies (MeSH)</term>
<term>Electronic Nicotine Delivery Systems (statistics & numerical data)</term>
<term>Female (MeSH)</term>
<term>Humans (MeSH)</term>
<term>Male (MeSH)</term>
<term>Quarantine (statistics & numerical data)</term>
<term>SARS-CoV-2 (MeSH)</term>
<term>Sexual and Gender Minorities (statistics & numerical data)</term>
<term>Surveys and Questionnaires (MeSH)</term>
<term>Tobacco Use Disorder (epidemiology)</term>
<term>United States (epidemiology)</term>
<term>Vaping (epidemiology)</term>
<term>Young Adult (MeSH)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adolescent (MeSH)</term>
<term>Comportement du consommateur (statistiques et données numériques)</term>
<term>Dispositifs électroniques d'administration de nicotine (statistiques et données numériques)</term>
<term>Enquêtes et questionnaires (MeSH)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Jeune adulte (MeSH)</term>
<term>Minorités sexuelles (statistiques et données numériques)</term>
<term>Mâle (MeSH)</term>
<term>Quarantaine (statistiques et données numériques)</term>
<term>Trouble lié au tabagisme (épidémiologie)</term>
<term>Vapotage (épidémiologie)</term>
<term>États-Unis (épidémiologie)</term>
<term>Études transversales (MeSH)</term>
</keywords>
<keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>United States</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Tobacco Use Disorder</term>
<term>Vaping</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Consumer Behavior</term>
<term>Electronic Nicotine Delivery Systems</term>
<term>Quarantine</term>
<term>Sexual and Gender Minorities</term>
</keywords>
<keywords scheme="MESH" qualifier="statistiques et données numériques" xml:lang="fr"><term>Comportement du consommateur</term>
<term>Dispositifs électroniques d'administration de nicotine</term>
<term>Minorités sexuelles</term>
<term>Quarantaine</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Trouble lié au tabagisme</term>
<term>Vapotage</term>
<term>États-Unis</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adolescent</term>
<term>COVID-19</term>
<term>Cross-Sectional Studies</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>SARS-CoV-2</term>
<term>Surveys and Questionnaires</term>
<term>Young Adult</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adolescent</term>
<term>Enquêtes et questionnaires</term>
<term>Femelle</term>
<term>Humains</term>
<term>Jeune adulte</term>
<term>Mâle</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>États-Unis</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>Importance</b>
</p>
<p>Understanding patterns of e-cigarette use and access during the coronavirus disease 2019 (COVID-19) pandemic is important because e-cigarettes may put users at risk for more severe respiratory effects and other health problems.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Objective</b>
</p>
<p>To examine whether underage youth and young adults who ever used e-cigarettes self-reported changes in access and use of e-cigarettes since the COVID-19 pandemic began.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Design, Setting, and Participants</b>
</p>
<p>A national, cross-sectional online survey study was conducted from May 6 to May 14, 2020. This sample of 4351 participants aged 13 to 24 years across the US included 2167 e-cigarette ever-users. Quota sampling was used to balance for age, sex, race/ethnicity, and 50% having ever used e-cigarettes.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Main Outcomes and Measures</b>
</p>
<p>Change in e-cigarette use (increase, decrease, quit, no change, and switch to another product) and access to e-cigarettes (easier or harder, and change in point-of-purchase) before and after the COVID-19 pandemic began, reasons for change, number of times e-cigarettes were used, nicotine dependence, and sociodemographic data.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Results</b>
</p>
<p>This study focused on 2167 e-cigarette ever-users among 4351 participants who completed the survey. Among 2167 e-cigarette users, a total of 1442 were younger than 21 years and 725 were aged 21 years or older; 1397 were female (64.5%) and 438 identified as lesbian, gay, bisexual, transgender, queer (20.2%). The survey completion rate was 40%. Since the COVID-19 pandemic began, 1198 of 2125 e-cigarette users (56.4%) changed their use: 388 individuals (32.4%) quit, 422 individuals (35.3%) reduced the amount of nicotine, 211 individuals (17.6%) increased nicotine use, 94 individuals (7.8%) increased cannabis use, and 82 individuals (6.9%) switched to other products. Participants reported that not being able to go to vape shops and product unavailability were the reasons accessing e-cigarettes was difficult after the pandemic began. Since the COVID-19 pandemic began, individuals reported purchasing from alternative retail stores (disposables, 150 of 632 [23.7%]; pod-based, 144 of 797 [18.1%]; and other e-cigarette, 125 of 560 [22.3%], ie, between 18.1% and 23.7%), purchasing online instead of retail (disposables, 115 of 632 [18.2%]; pod-based, 156 of 797 [19.6%]; and other e-cigarette, 111 of 560 [19.8%], ie, between 18.2% to 19.8%), and shifted to retail instead of online (disposables, 11 of 632 [1.7%]; pod-based, 17 of 797 [2.0%]; and other e-cigarette, 13 of 560 [2.3%], ie, between 1.7%-2.3%). Other individuals reported no change: from retail stores (disposables 262 of 632 [41.5%]; pod-based 344 of 797 [43.2%]; and other e-cigarette, 223 of 560 [39.8%], ie, between 39.8% and 43.2%) and online (disposables 94 of 632 [14.9%]; pod-based 136 of 797 [17.1%]; and other e-cigarette, 88 of 560 [15.8%], ie, between 14.9% and 17.1%). Underage youth reported e-cigarette deliveries from vape shops and/or dealers or friends who received such deliveries, and 63 of 229 (27.5%) self-reported accessing e-cigarettes without age verification. e-Cigarette users were 52% less likely to quit or reduce their use if they previously used e-cigarettes between 11 and 99 times (adjusted odds ratio, 0.48; 95% CI, 0.30-0.78), 68% less likely to quit if they previously used e-cigarettes more than 100 times (adjusted odds ratio, 0.32; 95% CI, 0.20-0.51), and 51% were less likely to quit if they were nicotine dependent (adjusted odds ratio, 0.49; 95% CI, 0.35-0.70).</p>
</div>
<div type="abstract" xml:lang="en"><p><b>Conclusions and Relevance</b>
</p>
<p>During the COVID-19 pandemic, youth e-cigarette users reported changes in e-cigarette use, point-of-purchase, and ability to purchase e-cigarettes without age verification. The US Food and Drug Administration and local policy makers may find these data useful to inform policies to prevent e-cigarette sales to underage youth.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33270127</PMID>
<DateCompleted><Year>2020</Year>
<Month>12</Month>
<Day>14</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>12</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2574-3805</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>3</Volume>
<Issue>12</Issue>
<PubDate><Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</PubDate>
</JournalIssue>
<Title>JAMA network open</Title>
<ISOAbbreviation>JAMA Netw Open</ISOAbbreviation>
</Journal>
<ArticleTitle>Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic.</ArticleTitle>
<Pagination><MedlinePgn>e2027572</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1001/jamanetworkopen.2020.27572</ELocationID>
<Abstract><AbstractText Label="Importance">Understanding patterns of e-cigarette use and access during the coronavirus disease 2019 (COVID-19) pandemic is important because e-cigarettes may put users at risk for more severe respiratory effects and other health problems.</AbstractText>
<AbstractText Label="Objective">To examine whether underage youth and young adults who ever used e-cigarettes self-reported changes in access and use of e-cigarettes since the COVID-19 pandemic began.</AbstractText>
<AbstractText Label="Design, Setting, and Participants">A national, cross-sectional online survey study was conducted from May 6 to May 14, 2020. This sample of 4351 participants aged 13 to 24 years across the US included 2167 e-cigarette ever-users. Quota sampling was used to balance for age, sex, race/ethnicity, and 50% having ever used e-cigarettes.</AbstractText>
<AbstractText Label="Main Outcomes and Measures">Change in e-cigarette use (increase, decrease, quit, no change, and switch to another product) and access to e-cigarettes (easier or harder, and change in point-of-purchase) before and after the COVID-19 pandemic began, reasons for change, number of times e-cigarettes were used, nicotine dependence, and sociodemographic data.</AbstractText>
<AbstractText Label="Results">This study focused on 2167 e-cigarette ever-users among 4351 participants who completed the survey. Among 2167 e-cigarette users, a total of 1442 were younger than 21 years and 725 were aged 21 years or older; 1397 were female (64.5%) and 438 identified as lesbian, gay, bisexual, transgender, queer (20.2%). The survey completion rate was 40%. Since the COVID-19 pandemic began, 1198 of 2125 e-cigarette users (56.4%) changed their use: 388 individuals (32.4%) quit, 422 individuals (35.3%) reduced the amount of nicotine, 211 individuals (17.6%) increased nicotine use, 94 individuals (7.8%) increased cannabis use, and 82 individuals (6.9%) switched to other products. Participants reported that not being able to go to vape shops and product unavailability were the reasons accessing e-cigarettes was difficult after the pandemic began. Since the COVID-19 pandemic began, individuals reported purchasing from alternative retail stores (disposables, 150 of 632 [23.7%]; pod-based, 144 of 797 [18.1%]; and other e-cigarette, 125 of 560 [22.3%], ie, between 18.1% and 23.7%), purchasing online instead of retail (disposables, 115 of 632 [18.2%]; pod-based, 156 of 797 [19.6%]; and other e-cigarette, 111 of 560 [19.8%], ie, between 18.2% to 19.8%), and shifted to retail instead of online (disposables, 11 of 632 [1.7%]; pod-based, 17 of 797 [2.0%]; and other e-cigarette, 13 of 560 [2.3%], ie, between 1.7%-2.3%). Other individuals reported no change: from retail stores (disposables 262 of 632 [41.5%]; pod-based 344 of 797 [43.2%]; and other e-cigarette, 223 of 560 [39.8%], ie, between 39.8% and 43.2%) and online (disposables 94 of 632 [14.9%]; pod-based 136 of 797 [17.1%]; and other e-cigarette, 88 of 560 [15.8%], ie, between 14.9% and 17.1%). Underage youth reported e-cigarette deliveries from vape shops and/or dealers or friends who received such deliveries, and 63 of 229 (27.5%) self-reported accessing e-cigarettes without age verification. e-Cigarette users were 52% less likely to quit or reduce their use if they previously used e-cigarettes between 11 and 99 times (adjusted odds ratio, 0.48; 95% CI, 0.30-0.78), 68% less likely to quit if they previously used e-cigarettes more than 100 times (adjusted odds ratio, 0.32; 95% CI, 0.20-0.51), and 51% were less likely to quit if they were nicotine dependent (adjusted odds ratio, 0.49; 95% CI, 0.35-0.70).</AbstractText>
<AbstractText Label="Conclusions and Relevance">During the COVID-19 pandemic, youth e-cigarette users reported changes in e-cigarette use, point-of-purchase, and ability to purchase e-cigarettes without age verification. The US Food and Drug Administration and local policy makers may find these data useful to inform policies to prevent e-cigarette sales to underage youth.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gaiha</LastName>
<ForeName>Shivani Mathur</ForeName>
<Initials>SM</Initials>
<AffiliationInfo><Affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lempert</LastName>
<ForeName>Lauren Kass</ForeName>
<Initials>LK</Initials>
<AffiliationInfo><Affiliation>Center for Tobacco Control Research & Education, University of California, San Francisco.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Halpern-Felsher</LastName>
<ForeName>Bonnie</ForeName>
<Initials>B</Initials>
<AffiliationInfo><Affiliation>Division of Adolescent Medicine, Department of Pediatrics, Stanford University, Palo Alto, California.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y"><Grant><GrantID>U54 HL147127</GrantID>
<Acronym>HL</Acronym>
<Agency>NHLBI NIH HHS</Agency>
<Country>United States</Country>
</Grant>
</GrantList>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>12</Month>
<Day>01</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>JAMA Netw Open</MedlineTA>
<NlmUniqueID>101729235</NlmUniqueID>
<ISSNLinking>2574-3805</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>JAMA Netw Open. 2020 Dec 1;3(12):e2028221</RefSource>
<PMID Version="1">33270120</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003258" MajorTopicYN="N">Consumer Behavior</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D066300" MajorTopicYN="N">Electronic Nicotine Delivery Systems</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011790" MajorTopicYN="N">Quarantine</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="Y">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000072339" MajorTopicYN="N">Sexual and Gender Minorities</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011795" MajorTopicYN="N">Surveys and Questionnaires</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014029" MajorTopicYN="N">Tobacco Use Disorder</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000072137" MajorTopicYN="N">Vaping</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>12</Month>
<Day>3</Day>
<Hour>12</Hour>
<Minute>9</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>12</Month>
<Day>4</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">33270127</ArticleId>
<ArticleId IdType="pii">2773494</ArticleId>
<ArticleId IdType="doi">10.1001/jamanetworkopen.2020.27572</ArticleId>
<ArticleId IdType="pmc">PMC7716191</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Addict Behav. 2018 Mar;78:120-123</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29154150</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Health Commun. 2019 Mar;34(3):290-297</Citation>
<ArticleIdList><ArticleId IdType="pubmed">29236550</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Adolesc Health. 2004 Sep;35(3):225-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15313504</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nicotine Tob Res. 2015 Jul;17(7):847-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25481917</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Adolesc Health. 2020 Oct;67(4):519-523</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32798097</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Toxicol. 2020 Jun;94(6):2261-2262</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32303807</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2017 Apr 15;195(8):1043-1049</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27806211</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tob Regul Sci. 2019 Mar;5(2):94-104</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31840040</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tob Control. 2017 Jul;26(4):471-475</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27543562</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tob Control. 2018 Sep 15;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30219794</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Adolesc Health. 2017 Sep;61(3):385-388</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28712593</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Nicotine Tob Res. 2014 Jun;16(6):655-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24336346</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Ann Am Thorac Soc. 2014 Feb;11(2):236-42</Citation>
<ArticleIdList><ArticleId IdType="pubmed">24575993</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tob Control. 2014 Mar;23(2):133-9</Citation>
<ArticleIdList><ArticleId IdType="pubmed">23467656</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Alcohol Depend. 2019 Jan 1;194:363-370</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30472577</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Tob Control. 2018 May;27(3):287-293</Citation>
<ArticleIdList><ArticleId IdType="pubmed">28484040</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Arch Pediatr Adolesc Med. 2002 Apr;156(4):397-403</Citation>
<ArticleIdList><ArticleId IdType="pubmed">11929376</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Alcohol Depend. 2019 Nov 1;204:107512</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31487572</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Alcohol Depend. 2016 Oct 01;167:224-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27592270</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Netw Open. 2018 Oct 5;1(6):e183535</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30646249</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Prev Med. 2017 Jan;94:65-71</Citation>
<ArticleIdList><ArticleId IdType="pubmed">27773711</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Drug Alcohol Depend. 2019 Jan 1;194:395-400</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30497057</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>Am J Respir Crit Care Med. 2019 Dec 1;200(11):1392-1401</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31390877</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2019 Oct 04;68(39):839-844</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31581163</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>MMWR Morb Mortal Wkly Rep. 2018 Nov 16;67(45):1276-1277</Citation>
<ArticleIdList><ArticleId IdType="pubmed">30439875</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA. 2019 Nov 5;:</Citation>
<ArticleIdList><ArticleId IdType="pubmed">31688912</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>JAMA Pediatr. 2015 Mar;169(3):e1563</Citation>
<ArticleIdList><ArticleId IdType="pubmed">25730697</ArticleId>
</ArticleIdList>
</Reference>
<Reference><Citation>J Adolesc Health. 2020 Jul;67(1):46-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">32192827</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>États-Unis</li>
</country>
<region><li>Californie</li>
</region>
<settlement><li>San Francisco</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Californie"><name sortKey="Gaiha, Shivani Mathur" sort="Gaiha, Shivani Mathur" uniqKey="Gaiha S" first="Shivani Mathur" last="Gaiha">Shivani Mathur Gaiha</name>
</region>
<name sortKey="Halpern Felsher, Bonnie" sort="Halpern Felsher, Bonnie" uniqKey="Halpern Felsher B" first="Bonnie" last="Halpern-Felsher">Bonnie Halpern-Felsher</name>
<name sortKey="Lempert, Lauren Kass" sort="Lempert, Lauren Kass" uniqKey="Lempert L" first="Lauren Kass" last="Lempert">Lauren Kass Lempert</name>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidStanfordV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000178 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000178 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Sante |area= CovidStanfordV1 |flux= Main |étape= Exploration |type= RBID |clé= pubmed:33270127 |texte= Underage Youth and Young Adult e-Cigarette Use and Access Before and During the Coronavirus Disease 2019 Pandemic. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:33270127" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \ | NlmPubMed2Wicri -a CovidStanfordV1
This area was generated with Dilib version V0.6.38. |